May 18 (Reuters) - Merck said on Monday its experimental endometrial cancer drug met the main goals of a late-stage trial.
Advertisement
(Reporting by Kamal Choudhury in Bengaluru)
ShowBiz & Sports
ERIUS MAG © 2015 | Distributed By My Blogger Themes | Designed By Templateism.com